Related references
Note: Only part of the references are listed.Gallstone Disease Does Not Predict Liver Histology in Nonalcoholic Fatty Liver Disease
Yusuf Yilmaz et al.
GUT AND LIVER (2014)
Nonalcoholic fatty liver disease and cholesterol gallstones: Which comes first?
Mohamed H. Ahmed et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Cholecystectomy and NAFLD: Does Gallbladder Removal Have Metabolic Consequences?
Flavio Nervi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Relationship of Non-alcoholic Fatty Liver Disease With Cholecystectomy in the US Population
Constance E. Ruhl et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
Donghee Kim et al.
HEPATOLOGY (2013)
FXR signaling in the enterohepatic system
Tsutomu Matsubara et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease
Anna Alisi et al.
PLOS ONE (2013)
Genetics of biliary lithiasis from an ethnic perspective
Marcin Krawczyk et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
CLINICAL AND MOLECULAR HEPATOLOGY (2013)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Naga Chalasani et al.
GASTROENTEROLOGY (2012)
The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract
Serge J. L. B. Zweers et al.
HEPATOLOGY (2012)
Gallstone Disease Is Associated with More Severe Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease
Anna Ludovica Fracanzani et al.
PLOS ONE (2012)
Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors
Tomas Koller et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes A 4-year retrospective longitudinal study
Ji Cheol Bae et al.
DIABETES CARE (2011)
The Bile Acid Membrane Receptor TGR5: A Valuable Metabolic Target
Thijs W. H. Pols et al.
DIGESTIVE DISEASES (2011)
Gallstones: Environment, Lifestyle and Genes
Caroline S. Stokes et al.
DIGESTIVE DISEASES (2011)
Nuclear Receptors in Liver Disease
Martin Wagner et al.
HEPATOLOGY (2011)
Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice
Ludwig Amigo et al.
LIVER INTERNATIONAL (2011)
Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism
Michael Trauner et al.
DIGESTIVE DISEASES (2010)
Epidemiology of Gallstones
Laura M. Stinton et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2010)
Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome
Federico Salamone et al.
JOURNAL OF HEPATOLOGY (2010)
Ethnic differences in body composition and the associated metabolic profile: A comparative study between Asians and Caucasians
S. N. Wulan et al.
MATURITAS (2010)
Known Risk Factors Do Not Explain Disparities in Gallstone Prevalence Between Denmark and Northeast Germany
Nele Friedrich et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
Sushant Bhatnagar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors
P Loria et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Relationship between pain symptoms and referred sensory and trophic changes in patients with gallbladder pathology
MA Giamberardino et al.
PAIN (2005)
Fibroblast growth factor 19 increases metabolic rate I and reverses dietary and leptlin-deficient diabetes
L Fu et al.
ENDOCRINOLOGY (2004)
Share Paper
